Microsatellite instability occurs in 15% of colorectal carcinomas and may be due to replication errors (RER). The pattern of instability ±`severe' vs`mild' ± and the tumorigenic pathway, as re¯ected by the involvement of functionally important genes, may vary according to the underlying gene(s). We de®ned`mild' RER as mono-or tetranucleotide repeat instability in the absence of widespread instability at dinucleotide repeats and studied 15 colorectal tumors with this phenotype for mutations in the DNA mismatch repair genes MSH2, MLH1, MSH3, and MSH6. No mutations were found, suggesting that these genes were not implicated. We then compared colorectal cancers with`mild' RER (n=15), and those with`severe' RER without (n=11) or with (n=22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFb RII. The combined mutation rates of the above mentioned loci varied signi®cantly between the three groups of tumors, being 0%, 25% and 52%, respectively. Furthermore, the individual genes showed speci®c patterns of involvement; for example, among tumors with`severe' RER, TGFb RII displayed uniformly high mutation rates while MSH3, MSH6, and BAX were more frequently altered in tumors that also showed MSH2 or MLH1 mutations. Our ®ndings suggest that dierent subcategories exist among unstable tumors, de®ned by the RER pattern on the one hand and tumorigenic pathway on the other, and structural changes of MSH2 and MLH1 are likely to explain only a proportion of these cases.
Introduction
Current models of cancer development are based on the experimental evidence that mutations accumulate in a stepwise fashion, leading to abnormalities in speci®c genes and resulting in clonal expansion of neoplastic cells (Fearon and Vogelstein, 1990) . It has been argued that the number of modi®cations in oncogenes and tumor suppressor genes is too high to be accounted for only by the spontaneous mutation rate, but a genetically unstable phenotype is required for multistep carcinogenesis (Loeb, 1991) . A novel mechanism of genetic instability has been elucidated in neoplasms from dierent organs, consisting of alterations in length (insertions or deletions) of repetitive sequences, microsatellites, interspersed along the whole genome Ionov et al., 1993; Thibodeau et al., 1993) . Such instability is a characteristic consequence of mutations in DNA mismatch repair genes that result in a failure to correct replication errors (RER) (reviewed in PeltomaÈ ki and de la . Homozygous mutations in`major' mismatch repair genes, such as MSH2 and MLH1 may give rise to secondary mutations in other genes which contain structural targets for mutations and are selected for during tumorigenesis (Malkhosyan et al., 1996) . Potential targets that have been proposed to play a role in colorectal tumorigenesis include other mismatch repair genes, for example MSH3 and MSH6 (also called GTBP) (Malkhosyan et al., 1996) , as well as other genes, such as the gene for transforming growth factor b receptor II (TGFb RII; Markowitz et al., 1995) , BAX (Rampino et al., 1997) , and the gene for insulin-like growth factor II receptor (IGFIIR; Souza et al., 1996) .
Since the earliest observations it became apparent that two types of microsatellite instability exist, depending on the number of the mutated markers, and on the degree of the increase or the decrease of the fragment size. Tumors with dramatic changes at a single locus often show a widespread instability at most of the studied microsatellite loci; they share certain clinical and pathological features like proximal location in the colon, poor dierentiation, and better prognosis (Thibodeau et al., 1993; Ionov et al., 1993; Lothe et al., 1993; Kim et al., 1994) . This pattern characterizes Hereditary Nonpolyposis Colorectal Carcinoma (HNPCC) tumors and around 10% of sporadic colorectal cancers, and is associated with mutations in MSH2, MLH1, or PMS2 in most tumors from the HNPCC group and in one-third of tumors from the sporadic group (Bùrresen et al., 1995; Liu et al., 1996; Konishi et al., 1996; Wu et al., 1997) . Less clear are the role and the mechanisms underlying lowlevel microsatellite instability. Based on observations in yeast, MSH3 and MSH6 whose protein products complex with the MSH2 protein in a partially redundant fashion (Marsischky et al., 1996) have been implicated in the explanation of the phenomenon. MSH6 recognizes mainly single-base mispairs and oneor two-nucleotide loops, and MSH6 mutant human tumors and cell lines show microsatellite instability primarily at mononucleotide tracts and apparently at lower rates than tumor cells with mutations in MSH2 or MLH1 (Papadopoulos et al., 1995; Akiyama et al., 1997) . Likewise, MSH3 mutations have been reported to be associated with only a moderate increase in microsatellite instability in yeast, aecting only simple repeats and preferentially leading to deletions (Strand et al., 1995) . Mutations in MSH3 in human endometrial tumors have been reported (Risinger et al., 1996) .
We studied colon cancers showing dierent levels of microsatellite instability with the aims (1) to better de®ne low-degree microsatellite instability by screening mild' RER positive tumors for mutations in the DNA mismatch repair genes MSH2, MLH1, MSH3 and MSH6, and (2) to study the sequence of events in the development of tumors with microsatellite instability, by analysing mononucleotide tracts in the coding regions of MSH3, MSH6, BAX and TGFb RII as hotspots for mutations.
Results

Microsatellite and mutation analyses in tumors with mild' RER
We de®ned`mild' RER as instability at mono-or tetranucleotide repeats in the absence of widespread dinucleotide repeat instability. Our panel of six monoor tetranucleotide repeat markers identi®ed 15 such tumors among those that had shown instability at one dinucleotide repeat locus, but had not satis®ed the de®nition of RER positivity (Table 1 ).
All 15 tumors were subjected to DNA-based mutation analyses and with the exception of cases 70, 313 and 5, RNA samples were available for reverse transcription-PCR (RT ± PCR) and in vitro synthesized protein (IVSP) analyses. The primers and reaction conditions are speci®ed in NystroÈ m- Lahti et al. (1996) , Chadwick et al. (1996) and in Table 2 and Materials and methods. To screen the MSH2 and MLH1 genes for mutations we started with RT ± PCR analyses of cDNA and continued by systematic sequencing of all exons and intron ± exon borders from genomic DNA. No mutations were found. Mutation analyses were then extended to MSH3 and MSH6 that could even be considered as better candidates to explain`mild' RER based on previous observations (see Introduction). However, no mutations were found in these genes, either, using the IVSP technique.
In the course of the above mentioned analyses, a number of single base substitutions were detected that were likely to represent innocuous polymorphisms because they did not generally lead to any coding changes and many have been reported to occur in the general population by us and others. The most common variants were (frequencies of the less common alleles in parentheses): in MSH2, G?A, 12 nucleotides downstream of exon 10 (23%) (Wijnen et al., 1994) , and T?C, six nucleotides upstream of exon 13 (20%) ; and in MLH1, G?A, 93 nucleotides upstream of the initiating methonine (43%) (Aaltonen et al., 1998) , and A?G, 19 nucleotides upstream of exon 15 (33%) (Wijnen et al., 1994) . The IVSP analysis occasionally yielded extra bands and although sequencing of the respective fragments did not reveal any truncating mutations, a homozygous missense change (G?A) at position 1865 of MSH3 was found in tumor cDNA from patient 54, changing Gly to Glu. The same alteration was present in normal mucosa from this patient and was subsequently found to occur as a polymorphic variant in the population with the allele frequencies of 81% for A and 19% for G.
MSH3, MSH6, BAX and TGFb RII mutations in`mild' and`severe' RER tumors
To explore whether the degree of microsatellite instability or the presence vs absence of detectable mutations in DNA mismatch repair genes might correlate with the rate of mutations in previously identi®ed target genes, mononucleotide stretches in MSH3, MSH6, BAX, and TGFb RII were examined in tumors with`mild' RER (n=15), as well as in those 
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This study Risinger et al. (1996 ) Risinger et al. (1996 N-MSH6-1F MSH6-1F MSH6-1R Originates from a family meeting the Amsterdam criteria for HNPCC (Vasen et al., 1991) ; f Loss of heterozygosity observed in tumor (Hemminki et al., 1994; Wu et al., 1997) with`severe' RER (n=33), 22 of which were known to have somatic and/or germline mutations in MSH2 or MLH1 while no mutations in these genes had been identi®ed in 11 (NystroÈ m-Lahti et al., 1996; Wu et al., 1997; Aaltonen et al., 1998) (Figure 1a) . Interestingly, the overall mutation rates, expressed as the proportions of mutated loci among all studied MSH3, MSH6, BAX, and TGFb RII loci, varied remarkably between these groups in that`mild' RER tumors showed no mutations at all whereas in tumors with`severe' RER, the rate was signi®cantly higher in those showing MSH2 or MLH1 mutations, compared to the remaining tumors with a similar RER phenotype (46/ 88, 52% vs 11/44, 25%, P=0.005) ( Table 3) . Calculated per tumors, frameshift mutations were found in up to 70% of tumors with`severe' RER; furthermore, MSH3, BAX and TGFb RII were frequently involved (42 ± 70%) whereas MSH6 mutations were far less common (12%; P50.001) and occurred only in tumors with demonstrable mutations in MSH2 or MLH1 (Table 3 and Figure 1b) . When the four genes were analysed separately in tumors without vs with MSH2 or MLH1 mutations (groups II and III in Figure 1b) , TGFb RII showed equally high mutation rates in both groups while MSH3, MSH6, and BAX were more frequently mutated in the latter group (for BAX, the dierence was statistically signi®cant with P=0.004). There was no apparent dierence in the patterns of mononucleotide tract instability between MSH2 vs MLH1-associated tumors, but the number of available tumors with MSH2 mutations was too small to make signi®cant comparisons.
Discussion
There is no consensus as to when a tumor should be designated as RER positive or RER negative. Initial studies suggested a distinction between single locus (41) and multilocus (52) involvement; however, the validity of this distinction strongly depends on the number of loci analysed, and later studies have typically required that for a tumor to be considered RER positive at least 30 ± 50% of microsatellite loci should be unstable, especially if the RER status is used to determine whether one should screen for germline mutations in DNA mismatch repair genes, i.e. undiagnosed cases of HNPCC (Canzian et al., 1996; Moslein et al., 1996; Dunlop et al., 1997) . A further possible source of variation in the detection rates of microsatellite instability is the type of marker used: for example, poly(A) repeats (Hoang et al., 1997) and triand tetranucleotide repeats (Mao et al., 1994) have been suggested to be more prone to deletion or expansion than dinucleotide repeats. Apart from HNPCC, the genetic basis of microsatellite instability in various tumors is poorly understood, and the possibility exists that dierent patterns of instability indicate dierent underlying genes (see Introduction). We de®ned the RER status based on both the number of unstable loci and the type of repeats involved. The tumors with`mild' RER were part of a larger series of sporadic colorectal cancers analysed for RER (Canzian et al., 1996; Aaltonen et al., 1998) . In regard to clinicopathological characteristics the present series of`mild' RER tumors was closer to the RER negative group than the group with typical RER but did not completely fall into either category. For example, the ratio of proximal to distal tumors was 40 ± 60%, being somewhat higher than in the RER negative tumors (27%/73%; P=0.07) but signi®cantly lower than in the RER positive ones (77%/23%; P50.001). Most tumors with`mild' RER were local representing Dukes stage A or B (67%); the percentage was signi®cantly higher than that for the RER negative tumors (58%, P=0.001) but lower than that for the RER positive ones (71%, P=0.59). The average age at diagnosis was relatively high (69.9 years) and similar to that calculated for all sporadic tumors, no matter whether RER negative or positive.
Even though the`mild' RER phenotype was characterized by a speci®c pattern of microsatellite instability (consisting of alterations at mono-or tetranucleotide repeats in the absence of widespread dinucleotide repeat changes) and a distinct clinicopathological pro®le, mutation analyses of DNA mismatch repair genes did not result in any distinguishing feature. No mutations were found either in genes associated with typical RER (MSH2 and MLH1) or in genes suggested to be responsible for a milder RER phenotype (MSH3 and MSH6). The screening strategy used for MSH2 and MLH1, RT ± PCR of cDNA and direct sequencing of genomic DNA, was expected to reveal most types of mutations including large deletions as well as point mutations in the exons,¯anking introns, and the promoter region, and its sensitivity was supported by the detection of numerous neutral sequence variants (see Results). The IVSP method used to screen for MSH3 and MSH6 mutations was expected to be somewhat less sensitive, being able to detect truncating mutations but not missense changes. Although technical shortcomings cannot be excluded as possible explanations for the lack of mutations in cases with`mild' RER it is, however, noteworthy that mutation analyses have not been able to identify the defective gene even in a majority of sporadic colorectal tumors with typical RER (Eshleman and Markowitz, 1996) . It is therefore possible that such as yet unidenti®ed genes that are involved in the latter cases also turn out to be important in the`mild' RER tumors. Alternatively, the`mild' RER phenotype may simply re¯ect background instability caused by the generally increased mutation rate in tumors.
Dierences in mutation frequencies in the mononucleotide tracts of MSH3, MSH6, BAX and TGFb RII suggested the presence of two subcategories of tumors with typical RER in accordance with a division based on the presence vs absence of MSH2 or MLH1 mutations in these tumors. Although con®rmation in a larger series is necessary, our ®nding of the combined mutation rates of MSH3, MSH6, BAX and TGFb RII being clearly higher for tumors with demonstrable MSH2 or MLH1 mutations as compared to those without mutations in these genes, implies that in addition to an MSH2/MLH1-associated pathway, a parallel`major' pathway is likely to exist, involving as yet unknown mechanisms. Dierent tumorigenic pathways in these two groups with high-degree instability were further highlighted by dierences observed in the mutation rates between individual target genes. Thus, while TGFb RII showed a frequent involvement (70%) in all tumors with severe RER, which is in accordance with previous reports of an important role of this gene in unstable colorectal tumors Parsons et al., 1995b) . MSH3, MSH6, and particularly BAX frameshift mutations were much more common in the group with MSH2 or MLH1 mutations than in the remaining tumors with severe RER. Furthermore, in keeping with the proposed partial redundancy of MSH3 and MSH6 proteins in DNA mismatch repair (Marsischky et al., 1996) it is of note that MSH6 mutations only occurred in the presence of MSH3 changes, and mutation of both genes possibly increased genetic destabilization, as illustrated by the high rate of concomitant BAX and TGFb RII mutations in these tumors ( Table 3) .
Genes that underlie microsatellite instability in cases with no apparent MSH2 or MLH1 mutations remain to be identi®ed. Other known genes with DNA mismatch repair function, as well as DNA polymerase d (da Costa et al., 1995) , are obvious candidates. Recently, a mechanism of DNA mismatch repair gene inactivation not involving structural changes in coding DNA was demonstrated by Kane et al. (1997) who showed a correlation between hypermethylation of the MLH1 promoter region and lack of expression of this gene in tumors with no detectable MLH1 mutations. It is possible that a proportion of sporadic tumors with microsatellite instability but no apparent mismatch repair gene mutations are attributable to inactivation of these genes by such epigenetic or other mechanisms. Furthermore, phenotypic manifestations of DNA mismatch repair gene mutations, including the degree of mismatch repair de®ciency and thus severity of microsatellite instability, may vary according to the nature of the gene defect, for example, depending on the ability of the mutated protein to inactivate the wild type protein by a dominant negative mechanism (Parsons et al., 1995a; JaÈ ger et al., 1997) . Studies to address these dierent possibilities in our tumor series are in progress.
Materials and methods
Tumor selection
De®nition of`mild' RER The tumors represented a series of 450 consecutive colorectal tumors previously analysed for RER status using 6 ± 14 dinucleotide repeat markers (Canzian et al., 1996) . Among those, we selected all samples (n=49) that were unstable at one or two loci, but did not meet the working de®nition of RER positivity requiring that at least three markers or at least 30% of the markers studied should be positive. These tumors were then studied with six additional markers detecting poly(A) or tetranucleotide repeats. Tumors with none of the markers being positive were considered RER negative and were not studied further. Tumors with at least one of these markers positive (n=15) were designated as having mild' RER and were selected for analysis of mutations in DNA mismatch repair genes. For comparison, we also studied a number of typical (`severe') RER tumors with the same mono-or tetranucleotide repeat markers and all tumors showed instability in the mono-and tetranucleotide repeats (data not shown).
Typical RER Thirty-three colorectal tumors were investigated, 22 of which were known to have germline and/or somatic mutations in MSH2 or MLH1, whereas no such mutations had been detected in 11 (Wu et al., 1997; NystroÈ m-Lahti et al., 1996; Aaltonen et al., 1998) .
Samples
RER and mutation analyses were conducted on DNA derived from fresh-frozen tumor tissue and paired normal mucosa or blood. The tissue specimens were cut into 5 mm sections, and the proportion of tumor cells was estimated by microscopy (all were above 60%). From these samples, DNA was extracted according to a non-enzymatic protocol (Lahiri and Nurnberger, 1991) . The RNeasy Total RNA kit (Qiagen GmbH, Hilden, Germany) was used for RNA extraction, according to the conditions suggested by the manufacturer.
Assessment of instability at microsatellite sequences
Methods for radioactive labeling and analysis of microsatellites have been previously described . The markers used to de®ne the`mild' RER category were: BAT 25, BAT 26, BAT 40, APD3, MYCL1, D19S244 (Ionov et al., 1993; Parsons et al., 1995b ; http:// gdbwww.gdb.org/). Frameshift mutations in the polynucleotide tracts of MSH3 [(A) 8 ] (Malkhosyan et al., 1996) , MSH6 [(C) 8 ] (Malkhosyan et al., 1996) , TGFb RII [(A) 10 ] (Parsons et al., 1995b) , and BAX [(G) 8 ] (Rampino et al., 1997) were studied using the published primer sequences.
Analysis of mutations
MSH2 and MLH1 To screen for possible splice site mutations and large deletions, the MSH2 and MLH1 cDNAs were studied in ®ve and six overlapping fragments, respectively, by RT ± PCR as previously described (NystroÈ m-Lahti et al., 1996) . Genomic DNA samples were studied by direct exon by exon sequencing of ampli®cation products generated with primers that were located in the¯anking introns approximately 50 bp from the respective intron/exon borders to detect all possible splice junction mutations . The sequences were determined on an Applied Biosystems 373 DNA sequencer using¯uorescently labeled primers and protocols supplied by the manufacturer (Applied Biosystems, Foster City, CA).
MSH3 and MSH6
The MSH3 and MSH6 cDNAs were divided into three overlapping fragments for the IVSP analysis according to Papadopoulos et al. (1995) and Risinger et al. (1996) , respectively, with modi®cations. The most important modi®cation was that half-nested reactions were used for all fragments so that a separate nesting forward primer was combined with the reverse primer in the ®rst run and the usual forward primer containing the consensus transcription-translation signal was combined with the same reverse primer in the second run. The primers used for IVSP are listed in Table 2 . The PCR reactions were carried out using 35 cycles, each consisting of 948C for 30 min, 558C for 1 h and 728C for 1 h, followed by a ®nal extension at 728C for 8 h. The TNT T7 Coupled Reticulocyte Lysate System (Promega, Madison, WI) was used for the in vitro synthesis of protein, according to the manufacturer's instructions, and the resulting proteins were size-separated through 4 ± 20% polyacrylamide gradient gels (Novex, San Diego, CA).
Statistical analysis
Chi-square test was used for assessing dierences between the groups.
